Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings entities : Johnson & johnson save search
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K
|
|
| O: -0.76%
H: 4.02%
C: 3.63%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
business year financial results
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
PTGX S | $26.82 0.79% 0.78% 340K
|
Health Technology
|
| O: 0.3%
H: 1.25%
C: -0.1%
year update financial results
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.2%
H: 2.52%
C: 1.3%
year financial results
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
LIVN | $55.01 1.85% 1.82% 640K
|
Health Technology
|
| O: 5.51%
H: 4.14%
C: 2.38%
results
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
MURA | $3.675 2.37% 2.31% 130K
|
|
| O: 2.78%
H: 8.11%
C: 3.53%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 2.72%
H: 13.77%
C: 13.25%
year financial results
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published: 2024-02-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
covid-19 sales drug
Kenvue Reports Full Year and Fourth Quarter 2023 Results
Published: 2024-02-08 (Crawled : 12:30) - biospace.com/
KVUE 4 | $19.37 -1.07% 0.0% 20M
|
n/a
|
| O: -3.27%
H: 0.98%
C: -2.62%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
year results
J&J Beats Q4 Expectations, Reports $21.4B in Revenue as Faces Patent Cliff
Published: 2024-01-23 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: 0.0%
patent revenue
Adimab Provides Year-End Update on 2023 Partnership Activities
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
partnership update
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
Published: 2023-11-29 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ARWR | $23.775 -0.61% -0.61% 830K
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: -1.7%
year pharmaceuticals results
Johnson & Johnson to Host Enterprise Business Review
Published: 2023-11-16 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.4%
H: 0.0%
C: 0.0%
business review
Biopharma Industry Continues to Bet Big on Antibody-Drug Conjugates
Published: 2023-10-20 (Crawled : 21:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
biopharma
J&J Sees Nearly 7% Growth in Q3, Increases Full-Year Guidance
Published: 2023-10-17 (Crawled : 15:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
growth
Week in Review: FTC Gets Tougher on Mergers, AAIC Data Dump, and Q2 Beat for ...
Published: 2023-07-21 (Crawled : 22:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.12%
H: 1.57%
C: 1.2%
aaic week
J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers
Published: 2023-07-20 (Crawled : 15:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 2.02%
H: 4.45%
C: 3.98%
pharma immunology
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Published: 2023-04-27 (Crawled : 12:20) - biospace.com/
TSVT | $4.63 -0.43% -0.43% 290K
|
|
| O: 0.71%
H: 8.58%
C: 5.64%
XYF | News | $3.882 -0.46% 0.0% 340
|
Finance
|
| O: -3.13%
H: 3.23%
C: 1.94%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.17%
H: 0.31%
C: 0.06%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.6%
financial results
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update
Published: 2023-03-29 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.28%
H: 0.75%
C: 0.7%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 3.0%
H: 4.33%
C: 2.88%
MIST | $1.67 2.45% 2.4% 90K
|
Health Technology
|
| O: 2.76%
H: 0.24%
C: -4.88%
MRNS | $1.455 -1.36% -1.37% 2.9M
|
Health Technology
|
| O: 1.28%
H: 12.5%
C: 10.28%
AGRX | $0.394 0.0% 16K
|
Health Technology
|
| O: 6.92%
H: 0.04%
C: -1.9%
year update pharmaceuticals financial results milestone
Sonnet BioTherapeutics Provides Fiscal Year 2023 First Quarter Business and Earnings Update
Published: 2023-02-13 (Crawled : 15:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.51%
H: 0.92%
C: 0.88%
SONN | $1.8 6.19% 5.83% 18K
|
Health Technology
|
| O: -3.74%
H: 4.3%
C: 1.08%
year update
Encision Reports Third Quarter Fiscal Year 2023 Results
Published: 2023-02-07 (Crawled : 11:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.08%
H: 1.41%
C: 1.11%
year results
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
Published: 2023-01-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: -3.82%
results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.